117 related articles for article (PubMed ID: 9871656)
1. Selective inhibition of the chymotrypsin-like activity of the 20S proteasome by 5-methoxy-1-indanone dipeptide benzamides.
Lum RT; Nelson MG; Joly A; Horsma AG; Lee G; Meyer SM; Wick MM; Schow SR
Bioorg Med Chem Lett; 1998 Feb; 8(3):209-14. PubMed ID: 9871656
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals).
Lynas JF; Harriott P; Healy A; McKervey MA; Walker B
Bioorg Med Chem Lett; 1998 Feb; 8(4):373-8. PubMed ID: 9871688
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells.
Fenteany G; Schreiber SL
Chem Biol; 1996 Nov; 3(11):905-12. PubMed ID: 8939705
[TBL] [Abstract][Full Text] [Related]
4. Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
Furet P; Imbach P; Fuerst P; Lang M; Noorani M; Zimmermann J; García-Echeverría C
Bioorg Med Chem Lett; 2002 May; 12(10):1331-4. PubMed ID: 11992770
[TBL] [Abstract][Full Text] [Related]
5. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
[TBL] [Abstract][Full Text] [Related]
6. An inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces arrest in G2-phase and metaphase in HeLa cells.
Wójcik C; Schroeter D; Stoehr M; Wilk S; Paweletz N
Eur J Cell Biol; 1996 Jun; 70(2):172-8. PubMed ID: 8793390
[TBL] [Abstract][Full Text] [Related]
7. The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome.
Figueiredo-Pereira ME; Chen WE; Li J; Johdo O
J Biol Chem; 1996 Jul; 271(28):16455-9. PubMed ID: 8663210
[TBL] [Abstract][Full Text] [Related]
8. P'-extended alpha-ketoamide inhibitors of proteasome.
Chatterjee S; Dunn D; Mallya S; Ator MA
Bioorg Med Chem Lett; 1999 Sep; 9(17):2603-6. PubMed ID: 10498217
[TBL] [Abstract][Full Text] [Related]
9. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex.
Vinitsky A; Michaud C; Powers JC; Orlowski M
Biochemistry; 1992 Oct; 31(39):9421-8. PubMed ID: 1356435
[TBL] [Abstract][Full Text] [Related]
11. Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.
Adams J; Behnke M; Chen S; Cruickshank AA; Dick LR; Grenier L; Klunder JM; Ma YT; Plamondon L; Stein RL
Bioorg Med Chem Lett; 1998 Feb; 8(4):333-8. PubMed ID: 9871680
[TBL] [Abstract][Full Text] [Related]
12. A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.
García-Echeverría C; Imbach P; France D; Fürst P; Lang M; Noorani AM; Scholz D; Zimmermann J; Furet P
Bioorg Med Chem Lett; 2001 May; 11(10):1317-9. PubMed ID: 11392545
[TBL] [Abstract][Full Text] [Related]
13. Effects of an inhibitor of tripeptidyl peptidase II (Ala-Ala-Phe-chloromethylketone) and its combination with an inhibitor of the chymotrypsin-like activity of the proteasome (PSI) on apoptosis, cell cycle and proteasome activity in U937 cells.
Bury M; Młynarczuk I; Pleban E; Hoser G; Kawiak J; Wójcik C
Folia Histochem Cytobiol; 2001; 39(2):131-2. PubMed ID: 11374791
[TBL] [Abstract][Full Text] [Related]
14. TMC-86A, B and TMC-96, new proteasome inhibitors from Streptomyces sp. TC 1084 and Saccharothrix sp. TC 1094. I. Taxonomy, fermentation, isolation, and biological activities.
Koguchi Y; Kohno J; Suzuki S; Nishio M; Takahashi K; Ohnuki T; Komatsubara S
J Antibiot (Tokyo); 1999 Dec; 52(12):1069-76. PubMed ID: 10695669
[TBL] [Abstract][Full Text] [Related]
15. TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities.
Koguchi Y; Kohno J; Nishio M; Takahashi K; Okuda T; Ohnuki T; Komatsubara S
J Antibiot (Tokyo); 2000 Feb; 53(2):105-9. PubMed ID: 10805568
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iinuma H; Ikeda D
Bioorg Med Chem Lett; 2005 Apr; 15(7):1867-71. PubMed ID: 15780623
[TBL] [Abstract][Full Text] [Related]
17. An inhibitor of the chymotrypsin-like activity of the proteasome (PSI) induces similar morphological changes in various cell lines.
Wójcik C
Folia Histochem Cytobiol; 1997; 35(4):211-4. PubMed ID: 9619420
[TBL] [Abstract][Full Text] [Related]
18. Effects of the combination of a proteasome inhibitor (PSI) and an inhibitor of ubiquitin-ligases (Leu-Ala) on the ultrastructure of human leukemic U937 cells.
Biały LP; Ziemba H; Pleban E; Wójcik C
Folia Histochem Cytobiol; 2002; 40(2):135-6. PubMed ID: 12056612
[TBL] [Abstract][Full Text] [Related]
19. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
Loidl G; Groll M; Musiol HJ; Ditzel L; Huber R; Moroder L
Chem Biol; 1999 Apr; 6(4):197-204. PubMed ID: 10099130
[TBL] [Abstract][Full Text] [Related]
20. Synthetic analogs of green tea polyphenols as proteasome inhibitors.
Smith DM; Wang Z; Kazi A; Li LH; Chan TH; Dou QP
Mol Med; 2002 Jul; 8(7):382-92. PubMed ID: 12393936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
